Leighann Ashlock, is a
Community Health Worker based in San Francisco, California. Leighann Ashlock is licensed to practice in California (license number ) and her current practice location is
2681 28th Ave, San Francisco, California. She can be reached at her office (for appointments etc.) via phone at
(681) 415-3211.
NPI number for Leighann Ashlock is 1073292918 and her current mailing address is 1263 Mission St, San Francisco, California. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1073292918.
Healthcare Provider's Profile
Full Name | Leighann Ashlock |
---|
Gender | Female |
---|
Speciality | Community Health Worker |
---|
Location | 2681 28th Ave, San Francisco, California |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1073292918
- Provider Enumeration Date: 07/17/2023
- Last Update Date: 05/19/2025
Medical Identifiers
Medical identifiers for Leighann Ashlock such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1073292918 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
101YA0400X | Counselor - Addiction (substance Use Disorder) | (California) | Secondary |
172V00000X | Community Health Worker | (California) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Leighann Ashlock is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Leighann Ashlock, 1263 Mission St, San Francisco, CA 94103-2705 Ph: (415) 502-3000 | Leighann Ashlock, 2681 28th Ave, San Francisco, CA 94116-2912 Ph: (681) 415-3211 |
Reviews and Comments